stockrow
Friday 6 November 2026
Export COAG’s income statement to Excel — free account
Hemab Therapeutics Holdings, Inc.
COAG Healthcare Biotechnology
48.60
3.03
+6.65%
Follow COAG
Alert me
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+1 more TTM period Free account |
— | — | — | 0.00% | |
| — | — | — | (31.79%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
— | 0.00% | 0.00% | (16.46%) | |
Free Cash Flow per Share |
0.00 | — | 0.00 | (2.42) | |
Free Cash Flow |
— | — | — | (72.74) | |
Capital Expenditures |
— | — | — | (0.15) | |
| Other line items | |||||
Cash ROIC |
0.00% | 0.00% | 0.00% | (7.98%) | |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
— | — | — | 0.00 | |
Research and Development Expense of Revenue |
— | — | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 0.00% | |
Share Based Compensation of Revenue |
— | — | — | 0.00% | |
Operating CF/Net income |
— | — | — | 0.98 | |
Depreciation/Fixed assets |
— | 0.00 | 0.00 | 0.50 | |
Capex/Depreciation |
— | — | — | (0.50) | |
Revenue per Share |
0.00 | — | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | — | 0.00 | (2.41) | |
Capex per Share |
0.00 | — | 0.00 | 0.00 | |
Capex to Sales |
— | — | — | 0.00 |
Columns are period end dates